Interleukin-6 and the IL-6 receptor have been identified in human prostate carcinoma (Siegsmund et al, 1994) and IL-6 acts as an autocrine and paracrine growth factor in androgen-refractory prostate cancer cells including PC-3 cells (Chung et al, 1999). Here, IL6 is linked to prostate carcinoma.